The Largest Biotech City in Europe Will Soon Be Built, With an Investment Amounting to 7 Billion Euros
Northway Group is embarking on a project to establish Europe’s largest biotechnology hub, BIO CITY, in Vilnius, the capital of Lithuania. It includes 6 large...
Latham BioPharm Group Awarded NIAID Preclinical Services IDIQ Contract Valued at Up to $30 Million
Latham BioPharm Group, part of SIA Partners, today announced receiving a new Indefinite Delivery, Indefinite Quantity (IDIQ) contract award from the National Institute of Allergy and...
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology
iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement...
AmplifyBio Celebrates 2 Years of Innovative Solutions, Preclinical Drug Development and Safety
AmplifyBio, an organization built from a preclinical CRO, launched out of Battelle in 2021 and dedicated to building a full-service advanced therapy commercialization hub, is...
Northway Biotech Set to Launch Advanced Microbial and Mammalian GMP Facilities in Massachusetts
Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site in Vilnius, Lithuania,...